Outlook Therapeutics, Inc. Note Agreements

11 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment, dated December 21, 2023, to the Convertible Promissory Note, dated December 22, 2022, by and between the Company and Streeterville Capital, LLC
Note Agreements
Outlook Therapeutics, Inc.
2023
Third Amendment to Convertible Promissory Note, dated January 22, 2024
Note Agreements
Outlook Therapeutics, Inc.
2024
Amendment, dated February 10, 2023, to the Convertible Promissory Note, dated December 22, 2022, by and between the Company and Streeterville Capital, LLC
Note Agreements
Outlook Therapeutics, Inc.
Biotechnology
2023
Form of Note
Note Agreements
Outlook Therapeutics, Inc.
Biotechnology
UT
2022
Note Amendment dated November 16, 2021
Note Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2021
Promissory Note dated November 16, 2021
Note Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2021
Note Purchase Agreement between the Company and Streeterville Capital, LLC, dated as of November 16, 2021
Note Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2021
Promissory Note dated November 4, 2020
Note Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2020
Note Purchase Agreement between the Company and Streeterville Capital, LLC, dated as of November 4, 2020
Note Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2020
Form of Senior Secured Promissory Note
Note Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2019
Third Note Amendment dated June 28, 2019
Note Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2019